NCT07426016

Brief Summary

Many preterm babies born between 22-28+6 weeks' estimated gestational age (EGA) need surfactant, a medicine that helps the lungs. The goal of the study is to compare the use of video-based visualization to direct visualization during a procedure called less invasive surfactant administration (LISA). The main questions the study aims to answer are: 1) does one method of visualization have a increased rate of giving the medicine successfully on the first attempt? 2) what benefits are there of each method?

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
28mo left

Started Apr 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress4%
Apr 2026Sep 2028

First Submitted

Initial submission to the registry

February 16, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 23, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

April 1, 2026

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2028

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2028

Last Updated

February 23, 2026

Status Verified

February 1, 2026

Enrollment Period

2 years

First QC Date

February 16, 2026

Last Update Submit

February 16, 2026

Conditions

Keywords

less invasive surfactantneonatalvideo laryngoscopy

Outcome Measures

Primary Outcomes (1)

  • Rate of first attempt success

    During procedure

Secondary Outcomes (19)

  • Duration of desaturation below 80% SpO2 (sec),

    during procedure

  • Duration of bradycardia (HR <100 bpm)

    procedure duration

  • Number of desaturation/bradycardia episodes

    during procedure

  • Number of surfactant installation attempts

    during procedure

  • Time to completion of surfactant installation

    during procedure

  • +14 more secondary outcomes

Study Arms (2)

Video Laryngoscopy

ACTIVE COMPARATOR

A video laryngoscopy will be used to visualize the vocal cords and place the LISA catheter for surfactant administration

Procedure: Video Laryngoscopy

Direct Laryngoscopy

ACTIVE COMPARATOR

Direct laryngoscopy (no camera) will be used to visualize the vocal cords and place the LISA catheter for surfactant administration

Procedure: Direct Laryngoscopy

Interventions

Video Laryngoscopy will be used to visualize the vocal cords and place the LISA catheter

Video Laryngoscopy

Direct Laryngoscopy will be used to visualize the vocal cords and place the LISA catheter

Direct Laryngoscopy

Eligibility Criteria

Age0 Hours - 3 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Infants born ≤28 weeks GA successfully resuscitated in the delivery room (DR) and maintained on CPAP • Need for surfactant in the first 36 hours of life based on clinical assessment and/or meeting threshold per unit protocol

You may not qualify if:

  • Infants born ≥29 weeks GA or
  • Infants with known congenital anomalies or
  • Infants who are determined by the primary care team to receive comfort care only or
  • Infants who are intubated at any time prior to surfactant administration

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Parkland Hospital

Dallas, Texas, 75235, United States

Location

Related Publications (5)

  • Aldana-Aguirre JC, Pinto M, Featherstone RM, Kumar M. Less invasive surfactant administration versus intubation for surfactant delivery in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2017 Jan;102(1):F17-F23. doi: 10.1136/archdischild-2015-310299. Epub 2016 Nov 15.

    PMID: 27852668BACKGROUND
  • Kurepa D, Boyar V, Predtechenska O, Gupta V, Weinberger B, Pulju M, Zaytseva A, Galanti SG, Kasniya G, Perveen S. Video laryngoscopy-assisted less-invasive surfactant administration quality improvement initiative. Arch Dis Child Fetal Neonatal Ed. 2023 Nov;108(6):588-593. doi: 10.1136/archdischild-2023-325357. Epub 2023 Apr 7.

    PMID: 37028921BACKGROUND
  • Riva T, Engelhardt T, Basciani R, Bonfiglio R, Cools E, Fuchs A, Garcia-Marcinkiewicz AG, Greif R, Habre W, Huber M, Petre MA, von Ungern-Sternberg BS, Sommerfield D, Theiler L, Disma N; OPTIMISE Collaboration. Direct versus video laryngoscopy with standard blades for neonatal and infant tracheal intubation with supplemental oxygen: a multicentre, non-inferiority, randomised controlled trial. Lancet Child Adolesc Health. 2023 Feb;7(2):101-111. doi: 10.1016/S2352-4642(22)00313-3. Epub 2022 Nov 24.

    PMID: 36436541BACKGROUND
  • Geraghty LE, Dunne EA, Ni Chathasaigh CM, Vellinga A, Adams NC, O'Currain EM, McCarthy LK, O'Donnell CPF. Video versus Direct Laryngoscopy for Urgent Intubation of Newborn Infants. N Engl J Med. 2024 May 30;390(20):1885-1894. doi: 10.1056/NEJMoa2402785. Epub 2024 May 5.

    PMID: 38709215BACKGROUND
  • Garcia-Marcinkiewicz AG, Kovatsis PG, Hunyady AI, Olomu PN, Zhang B, Sathyamoorthy M, Gonzalez A, Kanmanthreddy S, Galvez JA, Franz AM, Peyton J, Park R, Kiss EE, Sommerfield D, Griffis H, Nishisaki A, von Ungern-Sternberg BS, Nadkarni VM, McGowan FX Jr, Fiadjoe JE; PeDI Collaborative investigators. First-attempt success rate of video laryngoscopy in small infants (VISI): a multicentre, randomised controlled trial. Lancet. 2020 Dec 12;396(10266):1905-1913. doi: 10.1016/S0140-6736(20)32532-0.

    PMID: 33308472BACKGROUND

MeSH Terms

Conditions

Pulmonary Atelectasis

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract Diseases

Study Officials

  • Chokshi, MD

    UT Southwestern

    PRINCIPAL INVESTIGATOR
  • Shalini Ramachandran, MD

    UT Southwestern

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Principal Investigator, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

February 16, 2026

First Posted

February 23, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

April 1, 2028

Study Completion (Estimated)

September 1, 2028

Last Updated

February 23, 2026

Record last verified: 2026-02

Locations